X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Panacea Biotech Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Quarterly Results   (PANB)

Here are the latest quarterly results of Panacea Biotech. For more details, see the Panacea Biotech financial fact sheet and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Panacea Biotech Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-15
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,2211,2481,6481,5412,0321,2371,3721,022 
Other income Rs m16337746086112200137 
Turnover Rs m2,3841,2851,7211,6012,1171,3491,5721,159 
Expenses Rs m2,0791,1711,3981,3109771,1291,2691,024 
Gross profit Rs m142782505791,055107103-2 
Depreciation Rs m162186177181170166166165 
Interest Rs m438298317285243250255263 
Profit before tax Rs m-295-369-170174727-197-118-293 
Tax Rs m190005000 
Profit after tax Rs m-314-369-170174722-197-118-293 
Gross profit margin %6.46.215.237.651.98.77.5-0.2 
Effective tax rate %-6.40.00.00.00.70.00.00.0 
Net profit margin %-14.1-29.6-10.311.335.5-15.9-8.6-28.6 
Diluted EPS Rs -5.1 -6.0 -2.8 2.8 11.8 -3.2 -1.9 -4.8  
Diluted EPS (TTM) Rs -10.6 -12.8 -14.5 -11.1 5.8 8.6 9.5 1.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   AUROBINDO PHARMA  ALEMBIC PHARMA  SUVEN LIFE  DISHMAN PHARMA  ALEMBIC LTD  

Compare PANACEA BIOTECH With:   AUROBINDO PHARMA  ALEMBIC PHARMA  SUVEN LIFE  DISHMAN PHARMA  ALEMBIC LTD  

Compare PANACEA BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Flat; BPCL Tanks 2.2% on Weak Q4 Results(Closing)

Indian share markets continued to trade flat with positive bias during the afternoon session taking a breather after record closes in the previous few sessions.

Views on news

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Of "Shaky" Demonetisation Statistics, Arun Jaitley and Black Money(Vivek Kaul's Diary)

May 22, 2017

When it comes to identifying black money, 2016-2017 has been a fairly average year for the income tax department, demonetisation notwithstanding.

Just Like Before, the Market is about to Crash(Outside View)

May 17, 2017

Markets are at record highs. Fear is at record lows. How does this end? When does this end?

Why We Skipped This 70% Gainer(The 5 Minute Wrapup)

May 18, 2017

Underreporting of bad loans by some private sector banks casts a cloud over the sector's clean image so far.

Double Your Money with Derivatives(Daily Profit Hunter)

May 19, 2017

Asad Dossani discusses how you can double your money with derivatives.

The Rise and Fall of Shilpi Cable Technologies(Chart Of The Day)

May 19, 2017

How Shilpi Cable lost over 70% of its market cap in one month.

More

PANACEA BIOTECH SHARE PRICE


May 30, 2017 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - PLETHICO PHARMA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS